A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling During Rift Valley Fever Virus Infection
Overview
Affiliations
Unlabelled: Rift Valley fever virus (RVFV) is an arbovirus within the Bunyaviridae family capable of causing serious morbidity and mortality in humans and livestock. To identify host factors involved in bunyavirus replication, we employed genome-wide RNA interference (RNAi) screening and identified 381 genes whose knockdown reduced infection. The Wnt pathway was the most represented pathway when gene hits were functionally clustered. With further investigation, we found that RVFV infection activated Wnt signaling, was enhanced when Wnt signaling was preactivated, was reduced with knockdown of β-catenin, and was blocked using Wnt signaling inhibitors. Similar results were found using distantly related bunyaviruses La Crosse virus and California encephalitis virus, suggesting a conserved role for Wnt signaling in bunyaviral infection. We propose a model where bunyaviruses activate Wnt-responsive genes to regulate optimal cell cycle conditions needed to promote efficient viral replication. The findings in this study should aid in the design of efficacious host-directed antiviral therapeutics.
Importance: RVFV is a mosquito-borne bunyavirus that is endemic to Africa but has demonstrated a capacity for emergence in new territories (e.g., the Arabian Peninsula). As a zoonotic pathogen that primarily affects livestock, RVFV can also cause lethal hemorrhagic fever and encephalitis in humans. Currently, there are no treatments or fully licensed vaccines for this virus. Using high-throughput RNAi screening, we identified canonical Wnt signaling as an important host pathway regulating RVFV infection. The beneficial role of Wnt signaling was observed for RVFV, along with other disparate bunyaviruses, indicating a conserved bunyaviral replication mechanism involving Wnt signaling. These studies supplement our knowledge of the fundamental mechanisms of bunyavirus infection and provide new avenues for countermeasure development against pathogenic bunyaviruses.
Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions.
Owliaee I, Khaledian M, Shojaeian A, Madanchi H, Yarani R, Boroujeni A Probiotics Antimicrob Proteins. 2025; .
PMID: 39776036 DOI: 10.1007/s12602-024-10430-0.
Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia.
Rangel M, Bourguet F, Hall C, Weilhammer D Pathogens. 2024; 13(2).
PMID: 38392897 PMC: 10892077. DOI: 10.3390/pathogens13020159.
Wnt3a Facilitates SARS-CoV-2 Pseudovirus Entry into Cells.
Melano I, Chen H, Ngwira L, Hsu P, Kuo L, Noriega L Int J Mol Sci. 2024; 25(1).
PMID: 38203386 PMC: 10778646. DOI: 10.3390/ijms25010217.
Has Anti-Viral Activity in Rift Valley Fever Virus Infected .
Smith C, Hodges N, Kading R, Campbell C Viruses. 2023; 15(11).
PMID: 38005818 PMC: 10675198. DOI: 10.3390/v15112140.
Arm race between Rift Valley fever virus and host.
Wang X, Yuan Y, Liu Y, Zhang L Front Immunol. 2023; 13:1084230.
PMID: 36618346 PMC: 9813963. DOI: 10.3389/fimmu.2022.1084230.